Table of Content

Executive Summary



Chapter 1 – Introduction



Chapter 2 – Trends in central nervous system dealmaking



2.1. Introduction

2.2. Central nervous system partnering over the years

2.3. Central nervous system partnering by deal type

2.4. Central nervous system partnering by industry sector

2.5. Central nervous system partnering by stage of development

2.6. Central nervous system partnering by technology type

2.7. Central nervous system partnering by therapeutic indication



Chapter 3 – Financial deal terms for central nervous system partnering



3.1. Introduction

3.2. Disclosed financials terms for central nervous system partnering

3.3. Central nervous system partnering headline values

3.4. Central nervous system deal upfront payments

3.5. Central nervous system deal milestone payments

3.6. Central nervous system royalty rates



Chapter 4 – Leading central nervous system deals and dealmakers



4.1. Introduction

4.2. Most active in central nervous system partnering

4.3. List of most active dealmakers in central nervous system

4.4. Top central nervous system deals by value



Chapter 5 – Central nervous system contract document directory



5.1. Introduction

5.2. Central nervous system partnering deals where contract document available



Chapter 6 – Central nervous system dealmaking by therapeutic target



6.1. Introduction

6.2. Deals by central nervous system therapeutic target



Deal Directory



Deal Directory – Central nervous system deals by company A-Z 2016 to 2023

Deal Directory – Central nervous system deals by technology type 2016 to 2023



Deal type definitions



About Wildwood Ventures



Current Partnering

Current Agreements

Recent report titles from CurrentPartnering



Table of figures



Figure 1: Central nervous system partnering since 2016

Figure 2: Central nervous system partnering by deal type since 2016

Figure 3: Central nervous system partnering by industry sector since 2016

Figure 4: Central nervous system partnering by stage of development since 2016

Figure 5: Central nervous system partnering by technology type since 2016

Figure 6: Central nervous system partnering by indication since 2016

Figure 7: Central nervous system deals with a headline value

Figure 8: Central nervous system deals with upfront payment values

Figure 9: Central nervous system deals with milestone payment

Figure 10: Central nervous system deals with royalty rates

Figure 11: Active central nervous system dealmaking activity since 2016

Figure 12: Top central nervous system deals by value since 2016